CYCN: Cyclerion Therapeutics, Inc. Common Stock Company Profile & Statistics

About

Cyclerion Therapeutics Inc. is a clinical-stage biopharmaceutical company harnessing the power of sGC pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. The company's product pipeline consists of Olinciguat, Praliciguat and IW-6463 which are in clinical stage. Cyclerion Therapeutics Inc. is based in Cambridge, United States.

Info & Links

CEO

Regina Graul

Headquarters

245 FIRST STREET,18TH FLOOR
CAMBRIDGE, MA 02142, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

Cyclerion Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

7.32M

Enterprise Value

4.09M

Enterprise Value/EBITDA(ttm)

-1.13

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

0.90

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

50.00%

Operating Margin(ttm)

Profit Margin(ttm)

-85.83%

Return on Equity(ttm)

-55.32%

Return on Invested Capital(ttm)

-33.42%

Return on Assets(ttm)

-48.35%

Income Statement

Revenue(ttm)

2.00M

Revenue Per Share(ttm)

0.74

Gross Profit(ttm)

2.00M

EBITDA(ttm)³

-3.63M

Net Income Available to Common(ttm)

-3.06M

Diluted EPS(ttm)

Share Statistics

Beta (5Y Monthly)

1.74

52-Week Change

-3.28%

S&P 500 52-Week Change

6.00%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

2.71M

Dividend Yield

0.00%

Float⁴

1.73M

% Held by Insiders

36.10%

% Held by Institutions

75.62%

Balance Sheet

Total Cash(mrq)

3.23M

Total Cash Per Share(mrq)

1.19

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

5.83%

Quick Ratio(mrq)

5.07%

Book Value Per Share(mrq)

3.48

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.72

Free Cash Flow(ytd)

-4.33M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

CYCN

Cyclerion Therapeutics, Inc. Common Stock

Cyclerion Therapeutics, Inc. Common Stock Profile